24 August 2021 – Inventia Life Science, Biolamina AB, a Swedish biotechnology company leading in matrix biology and cell culture-based research, has entered into a partnership to supply 3D cell culture scaffolds, which include the RASTRUM™ platform Contains Human Recombinant Laminin Protein (Biolaminin®). In this partnership, Inventia Life Science will now offer Biolamina’s broad range of Biolamin® products, which will be incorporated into the existing library of RASTRUM™ matrices, reproducing key motifs found in native tissue of various cell types.
Laminin, an important protein found in the extracellular matrix (ECM) and microenvironment of cells and tissues, is generally required by cells for differentiation, migration and cellular adhesion. By incorporating laminin into in vitro cellular models, researchers are not only able to mimic the native ECM of various tissues, but also study the role of different laminin isoforms in disease progression and drug resistance mechanisms.
The partnership with Inventia Life Science marks a significant step forward in our ambition to demonstrate the role of laminin in a complex cellular assay. We strive to improve the quality and reliability of 3D cell culture by adding Biorelevant Biolamin® for tissue authentic cell responses. The RASTRUM™ platform adds significant customer value as it enables an automated workflow. “We look forward to taking this collaboration forward,” says Dr. Therese Kallur, Director of Business Development at Biolamina AB.
This new partnership aims to provide the next generation of complex 3D cell models incorporating Biolamina’s experience and product portfolio, which has already proven to be of high interest to many researchers, particularly those working in oncology settings . These laminin-containing 3D models can now be produced in a highly reproducible manner, while also being greatly promoted by the automated and high-throughput capabilities of the well-known RASTRUM™ 3D cell culture platform.
A physiologically relevant matrix environment is critical for our RASTRUM™ 3D cell model to recapitulate different cellular behaviors and phenotypes. BioLamina’s Biolaminins® enables our RASTRUM™ matrices to better mimic the in vivo extracellular-matrix microenvironment in a reproducible and tissue specific manner,” says Dr. Robert Utama, Lead Product Manager, Inventia Life Science.
BioLamina AB. about
Biolamina AB is a Swedish biotechnology company built on a scientific basis with a heritage in matrix biology and cell culture-based research. Our flagship product, our biorelevant human recombinant laminin isoform, BioLaminin®, are defined cell culture matrices that successfully mimic natural, cell-specific cell-matrix interactions in cell culture dishes, allowing cells to thrive and maintain their function. allowed to keep. Our products are a powerful resource for scientists working with stem cells and primary cells, both focused on basic research as well as cell therapy applications in regenerative medicine companies.